Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

PATHLINK OF NEW JERSEY

NPI: 1538821327 · DENVILLE, NJ 07834 · Anatomic Pathology & Clinical Pathology Physician · NPI assigned 10/08/2021

$554K
Total Medicaid Paid
115,231
Total Claims
83,297
Beneficiaries
92
Codes Billed
2021-12
First Month
2024-11
Last Month

Provider Details

Authorized OfficialGONZALEZ, MARIO (PRESIDENT)
NPI Enumeration Date10/08/2021

Related Entities

Other providers sharing the same authorized official: GONZALEZ, MARIO

ProviderCityStateTotal Paid
PRINCETON PATHOLOGY SERVICES PA NEWARK NJ $1.08M
PATHLINK OF NEW MEXICO LLC LAS CRUCES NM $379K
PATHLINK OF TEXAS, PLLC EL PASO TX $233K
HURON PATHOLOGY ASSOCIATES PLLC PORT HURON MI $162K
PATHLINK OF OHIO LLC SANDUSKY OH $39K
GARDEN STATE PHYSICIAN ASSOCIATES LLC VINELAND NJ $9K
PRINCETON PATHOLOGY SERVICES PLLC BRISTOL PA $7K
GT PSYCHIATRY LLC SAN JUAN PR $0.00

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2021 2,247 $15K
2022 15,743 $195K
2023 16,317 $173K
2024 80,924 $171K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
88305 Level IV - Surgical pathology, gross and microscopic examination 7,169 6,540 $359K
88307 1,360 1,295 $59K
80503 9,463 5,700 $43K
88342 3,326 3,141 $37K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1,097 1,035 $24K
88313 1,426 1,354 $11K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1,437 1,317 $7K
88304 324 304 $4K
G0452 Molecular pathology procedure; physician interpretation and report 314 293 $2K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 632 600 $2K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 2,108 1,838 $2K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 307 278 $2K
80500 275 138 $1K
80053 Comprehensive metabolic panel 11,444 7,159 $830.07
85025 Blood count; complete (CBC), automated, and automated differential WBC count 13,979 8,632 $332.35
0202U Oncology (prostate), multianalyte, gene expression profiling 131 126 $280.00
82962 1,282 351 $143.00
88302 13 13 $139.52
87040 875 730 $106.99
84484 1,549 1,228 $98.02
87070 1,580 1,415 $90.49
83735 5,209 2,218 $84.45
80048 Basic metabolic panel (calcium, ionized) 3,875 2,763 $82.91
80320 269 243 $81.78
80061 Lipid panel 921 799 $65.50
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 972 915 $60.37
87077 330 287 $48.48
82947 1,999 851 $47.89
84100 3,440 1,251 $44.47
81003 3,136 2,828 $39.52
85027 1,963 1,187 $38.73
87086 Culture, bacterial; quantitative colony count, urine 1,842 1,679 $38.28
83880 114 101 $37.94
83690 2,713 2,427 $34.86
87186 403 353 $33.30
83605 1,009 786 $29.79
83036 Hemoglobin; glycosylated (A1C) 662 606 $29.13
81001 2,933 2,678 $27.56
84443 Thyroid stimulating hormone (TSH) 752 652 $24.90
85014 216 126 $18.48
87177 17 16 $17.80
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 111 101 $17.55
85007 1,064 669 $16.91
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 924 887 $15.28
84702 362 318 $12.49
82550 694 489 $10.16
81002 60 56 $8.96
85610 2,381 1,848 $8.60
85730 1,927 1,577 $7.08
36415 Collection of venous blood by venipuncture 6,898 4,571 $7.01
87205 300 233 $3.43
82607 17 13 $2.94
82728 96 88 $2.73
81025 1,672 1,582 $2.00
85045 39 28 $1.39
86140 62 54 $0.00
82150 52 39 $0.00
86592 483 458 $0.00
82077 281 244 $0.00
87390 82 80 $0.00
85652 171 140 $0.00
86901 17 13 $0.00
85379 477 439 $0.00
82803 88 37 $0.00
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 195 182 $0.00
83550 114 103 $0.00
81015 14 12 $0.00
84703 229 211 $0.00
87340 16 16 $0.00
82746 18 13 $0.00
86803 110 108 $0.00
87081 45 39 $0.00
83615 50 44 $0.00
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 50 49 $0.00
82553 13 12 $0.00
85651 15 13 $0.00
87420 13 12 $0.00
82248 588 375 $0.00
80143 210 192 $0.00
80076 426 391 $0.00
80179 205 189 $0.00
84439 245 192 $0.00
84145 121 105 $0.00
82010 17 12 $0.00
87631 132 130 $0.00
82247 955 371 $0.00
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 60 59 $0.00
80354 118 117 $0.00
87634 16 16 $0.00
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 96 86 $0.00
83540 19 18 $0.00
86900 17 13 $0.00